Metabolites in Safety Testing – A Key to Turn for 
Your Drug Development Strategy
SOLUTIONS FOR ADVANCING YOUR TIMELINES. 
Wednesday, March 25th 
9:15-10:15 AM PT 
Room 24B

The changing pharmaceutical environment is delaying definitive nonclinical and clinical testing to after Phase IIB. Yet increasing regulatory requirements force organizations to look for alternative development plans. Learn how connections between toxicology and metabolism can help to de-risk your programs and blaze a path forward.

Presented by:
Head of In Vitro/Ex Vivo Study Direction

Executive Director, Global Drug Metabolism

FOLLOW US
Covance respects your Privacy.
Manage your Subscriptions.
© Copyright 2019 Covance Inc. All rights reserved.
Covance Header
Covance Footer